The aesthetic medicine market in Italy

Since 2020, the global market for aesthetic medicine and plastic surgery has grown significantly. Although the initial impact of the pandemic led to an almost 10% drop in the value of the Spanish market in 2020, to 2.6 billion euros, recovery has been rapid, with demand rebounding in 2021, influencede by factors such as increased personal savings during the downturn and a change in social dynamics leading to greater attention to virtual appearance. The sector is characterized by a high prevalence of non-surgical procedures, which account for 54.4% of the global market. In terms of regional dominance, the USA leads the way with 45% of the sector's revenues, followed by Europe with 25% and the Asia-Pacific region with 23%. Technology plays a key role in the market, as advances enable more effective and less invasive treatments. In the Spanish market, in particular, the popularity of aesthetic medicine has increased, with 35.9% of the population having recourse to this type of service, in

In France, the market for aesthetic medicine and surgery is worth around 10 to 15 billion euros. The global market for aesthetic surgery and medicine is estimated at $127 billion in 2023. Growth is being driven by technological innovations in aesthetic devices, increasing non-invasive treatment options and growing acceptance of aesthetic procedures, particularly in the Asia-Pacific region. The United States accounted for 45% of the market. In France, the market is growing at an annual rate of over 10-20%. More than 300,000 cosmetic surgery operations and over 400,000 aesthetic medicine procedures performed in 2022 Non-surgical procedures such as hyaluronic acid and botulinum toxin injections are on the rise The number of people having procedures is between 1 and 2 million. Demand for aesthetic services in France is strongly influenced by the fact that the boundary between aesthetics and medicine is blurring. Aesthetic medicine now accounts for around 50% of the market for aesthetic pro

As of 2020, the global market for cosmetic surgery and aesthetic medicine is experiencing robust growth, particularly emphasized by the rapid expansion in regions such as Asia-Pacific, which is seeing a growth rate of 10% per annum. The United States retains significant dominance in the market with a 44% share by value, while Brazil leads in terms of the volume of plastic surgery procedures. Non-surgical procedures, especially injectables like hyaluronic acid and botulinum toxin, dominate the market, constituting 38% and showing a projected CAGR of 8.3% through 2026. The market is also seeing an increase in the use of aesthetic devices employing advanced technologies such as non-invasive body reshaping systems. Medical tourism continues to rise, with a 15 to 20% increase registered, partly driven by cost disparities and the reputation of countries like Brazil for quality aesthetic medicine. Portugal's market can be gauged using data from Italy due to similar per capita spending on beau